comparemela.com

Latest Breaking News On - Odysseas manesiotis - Page 1 : comparemela.com

SIEMENS HEALTHINEERS : Berenberg maintains a Buy rating

Already positive, the research from Berenberg and its analyst Odysseas Manesiotis still consider the stock as a Buy opportunity. The target price remains unchanged at EUR 58.20.

Odysseas-manesiotis

QIAGEN NV : Berenberg maintains a Buy rating

In a research note, Berenberg analyst Odysseas Manesiotis has maintained his recommendation on the stock with a Buy rating. The target price remains unchanged at EUR 54.20.

Odysseas-manesiotis

QIAGEN NV : Berenberg reaffirms its Buy rating

In a research note, Berenberg analyst Odysseas Manesiotis has maintained his recommendation on the stock with a Buy rating. The target price is unchanged and still at EUR 54.20.

Odysseas-manesiotis
Markets

STRATEC BIOMEDICAL SYSTEMS AG : Berenberg reiterates its Neutral rating

In a research note published by Odysseas Manesiotis, Berenberg gives a Neutral rating to the stock. The target price is decreased from EUR 43 to EUR 41.

Odysseas-manesiotis
Markets

SARTORIUS VORZUEGE : Gets a Buy rating from Berenberg

Berenberg analyst Odysseas Manesiotis maintains his Buy rating on the stock. The target price is reduced from EUR 346 to EUR 330.

Odysseas-manesiotis

vimarsana © 2020. All Rights Reserved.